Table 2.

Additional information on participants from the patient and healthy control groups included in the study.

Patient	Sex	Age	Diagnosis	Seizure type	Seizure frequency (within 24 h)	Seizure duration	Time from sampling to seizure	EEG	Medication before blood sampling	Healthy control	Sex	Age
E-1	M	5 m	Epilepsy, infantile spasms	Spasm	5–6 times	2–10 min	1 h	Hypsarrhythmia	Chloral hydrate	C-1	M	6 y
E-2	F	14 m	Epilepsy	Generalized	5 times	3–5 min	1 h	Normal	Chloral hydrate	C-2	M	7 y
E-3	F	12 y	Epilepsy	Partial	5–6 times	1–2 min	1 h	Multifocal epileptic discharge	Carbamazepine	C-3	F	5 y
E-4	M	9 y	Epilepsy	Partial	5–6 times	1 min	4 h	Abnormal	Sodium valproate, Levetiracetam	C-4	F	8 y
E-5	F	5 m	Epilepsy	Generalized	2–3 times	0.5 min	1 h	Spike and slow wave emissions in the right occipital region	No medication	C-5	M	6 y
E-6	M	5 y	Epilepsy	Partial	1 time	30 min	1 h	Background rhythm slowed with no epileptic discharge	No medication	C-6	M	8 y
E-7	F	5 m	Epilepsy	Spasm	1 time	1 min	20 h	Hypsarrhythmia and seizures detected	No medication	C-7	M	8 y
E-8	M	15 m	Epilepsy	Spasm	3–4 times	Seconds	3 h	Spike and slow wave emissions in the central and parietal regions	No medication	C-8	M	7 y
E-9	M	14 y	Epilepsy	Partial	1 time	30 min	35 h	Spike and slow wave emissions in the central and parietal regions	No medication	C-9	M	10 y
E-10	M	5 m	Epilepsy	Partial	5–6 times	0.5–1 min	0.5 h	Epileptic discharge	Sodium valproate	C-10	M	9 y
E-11	M	3 y	Epilepsy	Partial	1 time	20 min	27 h	Epileptic discharge	No medication	C-11	M	3 y
E-12	F	15 m	Epilepsy	Partial	10 times	Seconds	1 h	Normal	No medication	C-12	F	10 m
E-13	F	15 m	Epilepsy	Generalized	3 times	1 min	1 h	Spike wave in the frontal area	Chloral hydrate	C-13	M	4 y
E-14	F	19 m	Epilepsy	Partial	8 times	1 min	1 h	Spike and slow wave emissions	Chloral hydrate	C-14	M	11 m